The pharmaceutical Contract Development and Manufacturing Organization (CDMO) market in India is experiencing substantial growth and transformation, positioning the country as a global hub for pharmaceutical development and manufacturing. This growth is led by several key factors that have synergistically fueled the expansion of the CDMO industry. First and foremost, India's well-established pharmaceutical industry, renowned for its generic drug production, is now diversifying into the development and manufacturing of innovative and complex drug products.
The Indian... >>More
Tarun Kumar, CEO, Lord’s Mark Biotech
Dr. TG Chandrashekar, Executive Director, Kusum Group of Companies
Venkatnarayanan K, Sr. Vice President & Head - Customer Services Zone, India Siemens Healthineers
Vinay Jain, Chief Operating Officer, Onelife Nutriscience
Sourabh Tiwari, CIO, Meril Group of Companies